- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB (publ) appoints Aaron Wong as Chief Executive Officer | 142 | GlobeNewswire (Europe) | The Board of Directors of Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has today appointed Aaron Wong as Chief Executive Officer of the Company on a permanent basis, effective... ► Artikel lesen | |
| 02.09. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB (publ) initiates implementation of restructuring following successful written procedure | 149 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), org. no. 556913-4710 (the "Company"), today on 2 September 2026 announces that it will initiate the implementation of the contemplated amendments and waivers as set... ► Artikel lesen | |
| 26.08. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 134 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), org. no. 556913-4710 (the "Company"), held today, on 26 August 2026, an extraordinary general meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B... ► Artikel lesen | |
| 17.08. | Decision by the Disciplinary Committee regarding Magle Chemoswed Holding AB | 246 | GlobeNewswire | Stockholm, August 17, 2026 - The Disciplinary Committee of Nasdaq Stockholm (the "Exchange") has found that Magle Chemoswed Holding AB (the "Company") has breached the rules of Nasdaq First North... ► Artikel lesen | |
| 12.08. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For Second Quarter 2026 | 118 | GlobeNewswire (Europe) | Early signs of stabilisation in a year of transition
Q2 2026 KEY INDICATORS (Apr-Jun)Total revenue amounted to 74.6 MSEK (55.2)EBITDA equalled 1.5 MSEK (-20.6)Operating profit (EBIT) was -13.1 MSEK... ► Artikel lesen | |
| 27.07. | The observation status for Magle Chemoswed Holding AB is updated | 241 | GlobeNewswire | On June 9, 2026, the shares in Magle Chemoswed Holding AB (the "Company") were given observation status with reference to uncertainty in respect of the issuer's financial position.
Today, July... ► Artikel lesen | |
| 27.07. | Magle Chemoswed Holding AB: The board of Magle Chemoswed Holding AB (publ) proposes that the EGM resolves on voluntary delisting of the company's shares from Nasdaq First North Growth Market | 265 | GlobeNewswire (Europe) | The board of directors of Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), has today resolved to propose that an extraordinary general meeting resolves on the delisting of the... ► Artikel lesen | |
| MAGLE CHEMOSWED Aktie jetzt für 0€ handeln | |||||
| 10.07. | Magle Chemoswed Holding AB: Magle Group Has Resolved On A Restructuring Of Its Outstanding Debt And Capital Structure, Including Debt-for-equity Swap, Issuance Of Super Senior Bonds And Directed Share Issues | 432 | GlobeNewswire (Europe) | As previously announced, Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has for some time been in constructive negotiations with bondholders representing approximately 79 per cent... ► Artikel lesen | |
| 30.06. | Magle Chemoswed Holding AB: Bulletin from the Annual General Meeting in Magle Chemoswed Holding AB (publ) | 209 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 30 June 2026, held its Annual General Meeting at the Company's premises at Agneslundsvägen 20B in Malmö. The following... ► Artikel lesen | |
| 25.06. | Magle Chemoswed Holding AB: Magle Group announces deferral of interest payment in respect of its bonds, and update to timing of intended financial restructuring | 235 | GlobeNewswire (Europe) | As communicated by Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") on 11 June 2026, the Company received a proposal from an ad hoc group of bondholders (the "Ad Hoc Group") in respect... ► Artikel lesen | |
| 09.06. | Magle Chemoswed Holding AB receives observation status | 209 | GlobeNewswire | On June 7, 2026, Magle Chemoswed Holding AB (the "Company") disclosed a press release with an update regarding the Company's financing arrangements.
According to item 6.1.3 (b) (iv) of the Nasdaq... ► Artikel lesen | |
| 07.06. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB - Update on Financing Arrangements and Ongoing Stakeholder Discussions | 261 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ) ("Magle" or the "Company") provides an update regarding its financing arrangements and ongoing discussions with key stakeholders.
Danske Bank Facility Maturing on 30... ► Artikel lesen | |
| 31.05. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For First Quarter 2026 | 229 | GlobeNewswire (Europe) | A difficult quarter in a year of necessary change
Q1 2026 KEY INDICATORSTotal revenue amounted to 71.7 MSEK (85.1)EBITDA equalled -6.6 MSEK (12.8)Operating profit (EBIT) was -17.8 MSEK (2.1)Profit after... ► Artikel lesen | |
| 26.05. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 308 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 26 May 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen | |
| 12.05. | New last trading day for paid subscription shares (BTA) of Magle Chemoswed Holding AB | 287 | GlobeNewswire | At the request of Magle Chemoswed Holding AB, the last trading day in Magle Chemoswed Holding AB's paid subscription shares will be changed from 2026-05-20 to 2026-05-13.
Instrument:
Paid subscription... ► Artikel lesen | |
| 30.04. | Magle Chemoswed Holding AB: Magle Group Announces Outcome of Rights Issue | 291 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 14.04. | Magle Chemoswed Holding AB: Magle Group Publishes Information Document in Connection with Upcoming Rights Issue | 320 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 13.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.04.2026 | 225 | Xetra Newsboard | Das Instrument LUR SE0015192075 LUXBRIGHT AB EQUITY wird ex Kapitalmassnahme gehandelt am 13.04.2026 The instrument LUR SE0015192075 LUXBRIGHT AB EQUITY is traded ex capital adjustment on 13.04.2026Das... ► Artikel lesen | |
| 10.04. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 234 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 10 April 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen | |
| 27.03. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2025 | 268 | GlobeNewswire (Europe) | Magle Group's Q4 report highlights restructuring measures, portfolio clean-up and a focus on improving profitability in a challenging financial environment.
Q4 2025 KEY INDICATORSNet Sales amounted... ► Artikel lesen |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 49,330 | +2,41 % | Biotech: Jetzt auf den Rebound setzen! Übernahmegefahr für Evotec und BioNxt, Bayer und BioNTech mit vollen Kassen | Der Biotech-Sektor steht nach einer langen Durststrecke vor einer spektakulären Trendwende, die mutigen Anlegern massive Renditechancen bietet. Denn die Kurse vieler innovativer Hoffnungsträger notieren... ► Artikel lesen | |
| MERCK KGAA | 130,55 | -0,68 % | BARCLAYS stuft MERCK KGAA auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Merck KGaA von 140 auf 150 Euro angehoben, aber die Einstufung auf "Equal Weight" belassen. Analyst James Gordon... ► Artikel lesen | |
| NOVO NORDISK | 37,725 | +0,12 % | Novo Nordisk meldet Erfolge bei Abnehmspritzen für Kindern, muss jedoch anderswo erneut Rückschläge verkraften | Novo Nordisk lieferte zu Beginn der Woche wieder einmal Neuigkeiten zu laufenden Studien und hatte dabei sowohl erfreuliche als auch enttäuschende Neuigkeiten im Gepäck. Eine große Überraschung blieb... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 16,000 | 0,00 % | Generate Biomedicines auf Healthcare-Konferenz: Pipeline gewinnt an Fahrt | ||
| NOVARTIS | 120,92 | +0,22 % | CH-Eröffnung: Novartis zieht SMI erneut nach unten | Zürich - Der SMI ist am Dienstag mit deutlich leichteren Notierungen in den regulären Handel gestartet. Belastet wird der Leitindex wie bereits am Vortag vor allem von Novartis nach einem weiteren Forschungsrückschlag.... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 57,57 | 0,00 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| SCHOTT PHARMA | 22,600 | -1,95 % | Community-Rückblick: wO-User zum Gerresheimer-CEO-Rücktritt: "Der Röhrhoff macht den Röhrhoff." | © Foto: Christoph Reichwein - dpaGerresheimer sorgt für Diskussionen: Der überraschende Abgang von Interim-CEO Röhrhoff und schwache Quartalszahlen werfen Fragen auf. Steht der Konzern vor dem Neustart... ► Artikel lesen | |
| DERMAPHARM | 37,900 | +1,34 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,885 | +0,10 % | Aquestive stellt auf H.C. Wainwright Konferenz Markteinführung von Anaphylm in den Fokus | ||
| PFIZER | 23,975 | -0,19 % | Pfizer auf Morgan Stanley Konferenz: Pipeline, KI und China im Fokus | ||
| KARDIGAN | 19,080 | +0,16 % | Kardigan auf Cantor-Konferenz: Plattformansatz für Herzmedikamente | ||
| ELI LILLY | 983,20 | -0,25 % | Eli Lilly, AbbVie und Johnson & Johnson: Wie der Fünf-Milliarden-Dollar-Pharma-Run auf Psychedelika Emyria in den Fokus rückt | ||
| SANOFI | 75,54 | +0,12 % | EU genehmigt Millionen für Sanofi-Insulinfabrik in Hessen | BRÜSSEL/FRANKFURT (dpa-AFX) - Um die Versorgung mit Insulin zu stärken, darf Deutschland den Arzneimittelhersteller Sanofi mit 400 Millionen Euro unterstützen. Das Unternehmen mit Sitz in Frankfurt... ► Artikel lesen | |
| OMNIAB | 4,475 | -0,11 % | Veraxa Biotech AG: VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb | VXA-222 advances into next phase at VERAXAZURICH, SWITZERLAND, July 27, 2026 --
VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA" or the "Company"), an emerging leader in designing novel cancer therapies... ► Artikel lesen | |
| LB PHARMACEUTICALS | 44,890 | +0,11 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027 Announced plans for pipeline expansion of LB-102 into... ► Artikel lesen |
MAGLE CHEMOSWED HOLDING AB gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell +4,55 % bei einem Aktienkurs von 0,012 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MAGLE CHEMOSWED HOLDING AB finden Sie auf Wallstreet Online.